Lv1
30 积分 2024-09-19 加入
Systematic surveillance of immune-related adverse events in clinical practice and impact of subsequent steroid medication on survival outcomes
18小时前
已完结
Immune Checkpoint Inhibitor Rechallenge Following Neurologic Immune-Related Adverse Events in Cancer Patients: A Systematic Review (P8-1.002)
2天前
求助中
Perioperative tislelizumab plus neoadjuvant chemotherapy for patients with resectable non-small-cell lung cancer (RATIONALE-315): an interim analysis of a randomised clinical trial
9天前
已完结
Safety and efficacy of restarting immune checkpoint inhibitors in non-small cell lung cancer patients following immune-related adverse events: a systematic review and meta-analysis
14天前
已完结
Mo1567 TREATMENT OUTCOMES OF IMMUNE CHECKPOINT INHIBITOR (ICI) HEPATITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS
22天前
已关闭
Rechallenge with anti-PD1 monotherapy after checkpoint inhibitor hepatitis is associated with low rates of recurrence: a single centre study
1个月前
已关闭
Tacrolimus Pharmacotherapy: Infectious Complications and Toxicity in Organ Transplant Recipients; An Updated Review
1个月前
已完结
Outcomes following immune checkpoint inhibitor re-challenge in patients who developed grade 3 and 4 hepatotoxicity
1个月前
已完结
Retreatment With Immune Checkpoint Inhibitors After a Severe Immune-Related Hepatitis: Results From a Prospective Multicenter Study
1个月前
已完结
Risk of hepatotoxicity in cancer patients treated with immune checkpoint inhibitors: A systematic review and meta‐analysis of published data
1个月前
已完结
皖公网安备34019202002308
